Back to Results
First PageMeta Content
Organochlorides / Bipolar spectrum / Amides / Organofluorides / Pyridines / Sorafenib / Quetiapine / Lithium pharmacology / Bipolar I disorder / Medicine / Chemistry / Organic chemistry


November 2013 PBAC Meeting Outcomes - "Subsequent" decisions not to recommend Drug and Form TGA Indication Current PBS Listing Listing Requested by Sponsor PBAC Outcome and Comments INGENOL MEBUTATE, gel, 0.15mg per g (
Add to Reading List

Document Date: 2015-01-19 17:21:09


Open Document

File Size: 75,50 KB

Share Result on Facebook

Company

LEO Pharma Pty Ltd / Bayer Australia Limited / AstraZeneca Pty Ltd / /

Event

Product Issues / FDA Phase / /

IndustryTerm

Treatment of acute mania associated with bipolar disorder / treatment of recurrent major depressive disorder / Treatment of depressive episodes associated with bipolar disorder Treatment / Pty Ltd Minor submission Bipolar disorder Treatment / treatment of bipolar I disorder / treatment of Advanced Barcelona Clinic Liver Cancer / /

MedicalCondition

keratoses / solar keratoses / squamous cell carcinoma / clear cell renal carcinoma / recurrent major depressive disorder / resistant major depression / IV renal cell carcinoma / acute mania / /

Organization

Medicare / /

Product

Seroquel XR / Nexavar / SK / evidence / /

ProvinceOrState

Saskatchewan / /

SocialTag